Hub : Traits :

Sensitivity / hurt feelings

539 significantly associated models · 55 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 52981087 54492569 3 1 1.9e-09 1.1e-08 5.7e-01 99 C1orf123
2 2 147993969 149475737 1 1 3.1e-07 3.9e-08 9.4e-03 78 ORC4
3 7 125383444 127590914 1 1 4.9e-11 4.3e-14 1.9e-06 60 GRM8
4 8 8092025 9669775 6 1 1.4e-09 6.6e-09 1.3e-02 82 FAM86B3P
5 8 10056664 11860845 7 1 7.6e-12 7.5e-11 1.1e-01 94 XKR6
6 8 141421996 142253369 1 1 1.5e-07 4.4e-07 7.8e-01 100 PTK2
7 9 33056378 34496024 1 1 7.2e-08 1.1e-07 4.2e-03 71 PRSS3
8 9 95502571 96898436 1 1 9.2e-09 1.7e-08 4.9e-01 98 RP11-165J3.6
9 9 97520168 98975128 1 1 6.1e-12 1.6e-11 2.3e-01 97 PTCH1
10 11 112950782 113591832 3 4 7.4e-10 8.9e-09 NaN NaN ANKK1 DRD2 TTC12
11 12 109231851 110729807 4 1 1.2e-07 7.0e-08 1.0e+00 100 MMAB
12 14 69412804 69954376 1 1 2.1e-07 3.0e-07 5.4e-02 86 EXD2
13 15 90718541 92120170 2 1 3.8e-08 3.2e-08 1.0e+00 100 FURIN
14 17 17484654 18914778 1 1 8.3e-08 4.1e-06 4.5e-03 62 TOP3A
15 17 42413481 45796313 21 1 5.4e-23 1.6e-21 4.3e-01 99 PLEKHM1
16 19 18829733 20313262 1 1 8.3e-08 9.7e-07 9.0e-01 100 GATAD2A

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Bipolar Disorder or Schizophrenia 3.6 3 1 2.2 0.00 1.0e+00 FAM86B3P FURIN GATAD2A
Depressed Affect (Nagel 2018) 11.5 12 6 13.3 0.98 3.6e-09 ANKK1 DRD2 EXD2 GRM8 MMAB ORC4 PLEKHM1 PTCH1 PTK2 RP11-165J3.6 TOP3A TTC12
Depression (Nagel 2018) 7.2 5 0 0.0 0.97 1.3e-03 ANKK1 PLEKHM1 RP11-165J3.6 TOP3A TTC12
Intelligence (Savage-Jansen 2018) 1.6 1 0 0.0 0.00 1.0e+00 PLEKHM1
Neuroticism (Nagel 2018) 16.5 14 11 24.4 0.98 3.2e-10 ANKK1 C1orf123 DRD2 EXD2 FURIN GRM8 MMAB ORC4 PLEKHM1 PTCH1 PTK2 RP11-165J3.6 TOP3A TTC12
Schizophrenia (2018) 3.9 2 1 2.2 0.00 1.0e+00 FURIN GATAD2A
Worry (Nagel 2018) 9.5 8 8 17.8 0.99 6.2e-07 ANKK1 DRD2 MMAB ORC4 PLEKHM1 PTCH1 RP11-165J3.6 TTC12
Verbal and Numeric Reasoning (VNR) 1.8 1 0 0.0 0.00 1.0e+00 PLEKHM1
Breast Cancer 3.3 3 2 4.4 0.00 1.0e+00 FURIN GATAD2A PLEKHM1
Ovarian Cancer 2.8 1 1 2.2 0.00 1.0e+00 PLEKHM1
HDL Cholesterol 2.5 1 1 2.2 0.00 1.0e+00 MMAB
Lupus 2.6 2 0 0.0 0.00 1.0e+00 FAM86B3P XKR6
Neuroticism (2016) 10.3 6 3 6.7 0.96 2.4e-03 ANKK1 DRD2 FAM86B3P PLEKHM1 TTC12 XKR6
Primary Biliary Cirrhosis 1.4 1 0 0.0 0.00 1.0e+00 PLEKHM1
Schizophrenia (2014) 4.5 4 2 4.4 0.58 4.2e-01 DRD2 FAM86B3P FURIN GATAD2A
Triglycerides 2.0 1 0 0.0 0.00 1.0e+00 GATAD2A
Blood Eosinophil Count 2.0 4 4 8.9 -0.08 9.2e-01 GATAD2A ORC4 PLEKHM1 TOP3A
Blood Platelet Count 1.3 2 1 2.2 0.00 1.0e+00 GATAD2A PTK2
Blood Red Count 2.7 3 1 2.2 0.00 1.0e+00 DRD2 EXD2 PLEKHM1
Blood White Count 1.1 4 2 4.4 -0.02 9.8e-01 FURIN PLEKHM1 PTCH1 TTC12
Heel T-Score 1.0 1 1 2.2 0.00 1.0e+00 PLEKHM1
BMI 1.5 4 1 2.2 1.00 4.6e-05 ANKK1 EXD2 MMAB TTC12
Height 1.0 5 4 8.9 0.53 3.6e-01 FURIN PLEKHM1 PTCH1 RP11-165J3.6 TOP3A
Waist Hip Ratio (WHR) 2.1 4 1 2.2 1.00 1.2e-03 ANKK1 PLEKHM1 PTK2 TTC12
Systolic Blood Pressure 3.5 5 3 6.7 -0.53 3.6e-01 FURIN MMAB PLEKHM1 PTK2 TOP3A
Smoking Status 1.7 1 0 0.0 0.00 1.0e+00 EXD2
Cardiovascular Disease 2.9 5 1 2.2 0.51 3.0e-01 ANKK1 DRD2 FURIN TOP3A TTC12
Lung FEV1/FVC ratio 2.1 3 1 2.2 0.00 1.0e+00 PLEKHM1 PTCH1 PTK2
Lung FVC 4.0 2 2 4.4 0.00 1.0e+00 PLEKHM1 PTCH1
Neuroticism 15.4 13 9 20.0 0.98 2.4e-09 ANKK1 DRD2 EXD2 FURIN GRM8 MMAB ORC4 PLEKHM1 PTCH1 PTK2 RP11-165J3.6 TOP3A TTC12
Hand grip strength (left) 1.7 1 1 2.2 0.00 1.0e+00 PLEKHM1
Number of treatments/medications taken 3.3 1 0 0.0 0.00 1.0e+00 TTC12
Frequency of depressed mood in last 2 weeks 6.9 4 0 0.0 1.00 4.2e-03 ANKK1 DRD2 PLEKHM1 RP11-165J3.6
Hearing difficulty/problems: Yes 3.5 2 1 2.2 0.00 1.0e+00 MMAB PTK2
Relative age of first facial hair 3.0 1 1 2.2 0.00 1.0e+00 PLEKHM1
Other serious medical condition/disability diagnosed by doctor 3.5 2 0 0.0 0.00 1.0e+00 ANKK1 TTC12
Systolic blood pressure, automated reading 4.0 4 4 8.9 -0.93 6.7e-02 FAM86B3P FURIN PLEKHM1 XKR6
Angina 1.9 1 1 2.2 0.00 1.0e+00 FURIN
Impedance of leg (right) 3.4 7 3 6.7 0.15 7.4e-01 FAM86B3P FURIN GATAD2A MMAB PLEKHM1 PTCH1 XKR6
Leg fat-free mass (left) 2.0 6 3 6.7 -0.07 8.9e-01 FAM86B3P FURIN GATAD2A MMAB PTCH1 XKR6
Trunk fat percentage 2.1 4 1 2.2 0.39 5.1e-01 ANKK1 EXD2 PLEKHM1 TTC12
Hand grip strength (right) 1.4 1 1 2.2 0.00 1.0e+00 PLEKHM1
Current tobacco smoking 3.7 1 0 0.0 0.00 1.0e+00 EXD2
Fed-up feelings 8.2 9 4 8.9 0.99 8.3e-07 ANKK1 DRD2 EXD2 FAM86B3P ORC4 PLEKHM1 PTK2 TTC12 XKR6
Frequency of unenthusiasm / disinterest in last 2 weeks 6.8 4 0 0.0 1.00 7.8e-05 ANKK1 DRD2 EXD2 TTC12
Relative age voice broke 2.3 1 1 2.2 0.00 1.0e+00 PLEKHM1
Taking other prescription medications 3.2 1 0 0.0 0.00 1.0e+00 GATAD2A
Age when periods started (menarche) 1.8 1 0 0.0 0.00 1.0e+00 PLEKHM1
Heel bone mineral density (BMD) T-score, automated (left) 4.3 2 2 4.4 0.00 1.0e+00 FAM86B3P XKR6
High blood pressure 4.4 4 3 6.7 -0.65 3.5e-01 FAM86B3P FURIN TOP3A XKR6
Medication: Atenolol 1.5 1 0 0.0 0.00 1.0e+00 FURIN
Medication: Levothyroxine sodium 2.5 2 0 0.0 0.00 1.0e+00 FAM86B3P XKR6
Sitting height 2.4 2 2 4.4 0.00 1.0e+00 PLEKHM1 PTCH1
High blood pressure (mother) 2.4 1 1 2.2 0.00 1.0e+00 FURIN
Body mass index (BMI) 2.5 2 2 4.4 0.00 1.0e+00 FAM86B3P XKR6
Impedance of leg (left) 3.4 6 4 8.9 0.49 3.3e-01 FAM86B3P FURIN GATAD2A MMAB PLEKHM1 XKR6
Leg predicted mass (left) 2.0 6 3 6.7 -0.08 8.8e-01 FAM86B3P FURIN GATAD2A MMAB PTCH1 XKR6
Trunk fat mass 2.1 5 1 2.2 0.39 4.4e-01 ANKK1 EXD2 PLEKHM1 TTC12 XKR6
Waist circumference 2.2 2 2 4.4 0.00 1.0e+00 ANKK1 TTC12
Number of incorrect matches in round 2.3 1 1 2.2 0.00 1.0e+00 FURIN
Nervous feelings 9.3 6 3 6.7 0.96 2.5e-03 ANKK1 FAM86B3P ORC4 PLEKHM1 TTC12 XKR6
Frequency of tenseness / restlessness in last 2 weeks 8.3 7 2 4.4 0.99 1.1e-05 ANKK1 DRD2 MMAB PLEKHM1 RP11-165J3.6 TOP3A TTC12
Hearing difficulty/problems with background noise 4.9 4 0 0.0 0.99 1.4e-02 ANKK1 MMAB PLEKHM1 TTC12
Hair/balding pattern: Pattern 2 2.3 1 1 2.2 0.00 1.0e+00 PLEKHM1
Forced vital capacity (FVC) 3.7 2 2 4.4 0.00 1.0e+00 PLEKHM1 PTCH1
Heel bone mineral density (BMD) T-score, automated (right) 4.4 2 2 4.4 0.00 1.0e+00 FAM86B3P XKR6
Ever unenthusiastic/disinterested for a whole week 2.4 1 0 0.0 0.00 1.0e+00 PLEKHM1
Financial difficulties in last 2 years 4.0 1 0 0.0 0.00 1.0e+00 DRD2
Mouth/teeth dental problems 3.3 1 0 0.0 0.00 1.0e+00 PLEKHM1
Heart attack 2.3 1 0 0.0 0.00 1.0e+00 FURIN
Allergy 2.2 1 0 0.0 0.00 1.0e+00 FURIN
Fluid intelligence score 1.4 1 0 0.0 0.00 1.0e+00 PLEKHM1
Neuroticism score 18.4 15 10 22.2 0.97 3.7e-10 ANKK1 C1orf123 DRD2 EXD2 FAM86B3P GRM8 MMAB ORC4 PLEKHM1 PTCH1 PTK2 RP11-165J3.6 TOP3A TTC12 XKR6
Weight 1.9 4 1 2.2 -0.01 9.8e-01 ANKK1 FAM86B3P TTC12 XKR6
Impedance of arm (right) 2.4 3 3 6.7 0.00 1.0e+00 FAM86B3P PLEKHM1 XKR6
Arm fat percentage (right) 2.3 5 0 0.0 0.24 6.4e-01 ANKK1 EXD2 FAM86B3P TTC12 XKR6
Trunk fat-free mass 1.5 3 1 2.2 0.00 1.0e+00 GATAD2A PTCH1 XKR6
Hip circumference 1.8 5 1 2.2 0.14 7.9e-01 ANKK1 FAM86B3P PTCH1 TTC12 XKR6
Father's age at death 2.5 1 0 0.0 0.00 1.0e+00 XKR6
Worrier / anxious feelings 10.6 7 3 6.7 0.92 3.1e-03 FAM86B3P MMAB ORC4 PLEKHM1 PTCH1 RP11-165J3.6 XKR6
Frequency of tiredness / lethargy in last 2 weeks 7.8 6 3 6.7 0.99 5.0e-05 ANKK1 EXD2 MMAB PTK2 RP11-165J3.6 TTC12
Hair/balding pattern: Pattern 3 4.1 1 1 2.2 0.00 1.0e+00 PLEKHM1
Number of live births 2.4 2 0 0.0 0.00 1.0e+00 PLEKHM1 TOP3A
Forced expiratory volume in 1-second (FEV1) 3.4 3 2 4.4 0.00 1.0e+00 FAM86B3P PLEKHM1 PTCH1
Qualifications: A levels/AS levels or equivalent 1.6 1 0 0.0 0.00 1.0e+00 PLEKHM1
Medication: Ibuprofen (e.g. Nurofen) 1.9 1 0 0.0 0.00 1.0e+00 PLEKHM1
Medication: Cholesterol lowering 2.7 2 0 0.0 0.00 1.0e+00 EXD2 GATAD2A
Forced expiratory volume in 1-second (FEV1), Best measure 3.0 2 1 2.2 0.00 1.0e+00 PLEKHM1 PTCH1
Impedance of arm (left) 2.3 3 3 6.7 0.00 1.0e+00 FAM86B3P PLEKHM1 XKR6
Arm fat mass (right) 2.5 4 2 4.4 0.00 9.9e-01 ANKK1 FAM86B3P TTC12 XKR6
Trunk predicted mass 1.5 3 1 2.2 0.00 1.0e+00 GATAD2A PTCH1 XKR6
Standing height 1.2 5 2 4.4 0.56 3.2e-01 FAM86B3P PLEKHM1 PTCH1 RP11-165J3.6 TOP3A
Tense / 'highly strung' 9.6 9 3 6.7 0.99 7.4e-08 ANKK1 C1orf123 DRD2 FAM86B3P ORC4 PTCH1 RP11-165J3.6 TTC12 XKR6
Seen doctor (GP) for nerves, anxiety, tension or depression 6.3 3 1 2.2 0.00 1.0e+00 ANKK1 DRD2 TTC12
Hair/balding pattern: Pattern 4 5.3 1 1 2.2 0.00 1.0e+00 PLEKHM1
Birth weight of first child 2.6 1 1 2.2 0.00 1.0e+00 FURIN
Peak expiratory flow (PEF) 3.3 3 1 2.2 0.00 1.0e+00 FAM86B3P PLEKHM1 XKR6
Medication: Paracetamol 3.5 1 1 2.2 0.00 1.0e+00 PLEKHM1
Headache pain in last month 4.3 1 1 2.2 0.00 1.0e+00 PLEKHM1
Medication for cholesterol, blood pressure or diabetes 2.5 1 0 0.0 0.00 1.0e+00 FURIN
Hypothyroidism/myxoedema (self-reported) 3.2 2 2 4.4 0.00 1.0e+00 FAM86B3P XKR6
Birth weight 2.6 2 2 4.4 0.00 1.0e+00 FURIN PTCH1
Forced vital capacity (FVC), Best measure 3.5 3 2 4.4 0.00 1.0e+00 EXD2 PLEKHM1 PTCH1
Body fat percentage 2.3 3 1 2.2 1.00 1.1e-03 ANKK1 EXD2 TTC12
Leg fat percentage (right) 2.5 5 1 2.2 0.33 5.3e-01 ANKK1 EXD2 FAM86B3P TTC12 XKR6
Arm fat-free mass (right) 1.5 3 1 2.2 0.00 1.0e+00 FAM86B3P PTCH1 XKR6
Comparative body size at age 10 3.1 4 3 6.7 -0.99 5.1e-03 FAM86B3P GATAD2A RP11-165J3.6 XKR6
Worry too long after embarrassment 10.6 6 5 11.1 0.96 4.9e-04 ANKK1 DRD2 FAM86B3P PLEKHM1 TTC12 XKR6
Seen a psychiatrist for nerves, anxiety, tension or depression 4.0 1 1 2.2 0.00 1.0e+00 C1orf123
Wheeze or whistling in the chest in last year 3.0 2 0 0.0 0.00 1.0e+00 ANKK1 RP11-165J3.6
Age at first live birth 3.1 2 0 0.0 0.00 1.0e+00 GATAD2A PLEKHM1
Health satisfaction 4.2 1 0 0.0 0.00 1.0e+00 DRD2
Qualifications: College or University degree 2.2 2 1 2.2 0.00 1.0e+00 EXD2 PLEKHM1
Medication for pain relief, constipation, heartburn 2.4 2 1 2.2 0.00 1.0e+00 PLEKHM1 RP11-165J3.6
Neck or shoulder pain in last month 2.6 2 0 0.0 0.00 1.0e+00 EXD2 PTK2
Medication: Blood pressure 3.0 3 0 0.0 0.00 1.0e+00 FURIN TOP3A XKR6
Angina (self-reported) 1.8 1 0 0.0 0.00 1.0e+00 FURIN
Whole body fat mass 2.3 5 1 2.2 0.29 5.7e-01 ANKK1 EXD2 FAM86B3P TTC12 XKR6
Leg fat mass (right) 2.6 5 3 6.7 0.21 7.0e-01 ANKK1 EXD2 FAM86B3P TTC12 XKR6
Arm predicted mass (right) 1.5 3 1 2.2 0.00 1.0e+00 FAM86B3P PTCH1 XKR6
Alcohol intake frequency. 3.2 3 1 2.2 0.00 1.0e+00 DRD2 PLEKHM1 TOP3A
Comparative height size at age 10 1.5 3 1 2.2 0.37 6.3e-01 ANKK1 PLEKHM1 PTCH1
Suffer from 'nerves' 7.6 6 2 4.4 0.99 3.3e-04 ANKK1 DRD2 FAM86B3P PTCH1 TTC12 XKR6
Overall health rating 5.6 5 2 4.4 0.65 1.6e-01 ANKK1 PTK2 RP11-165J3.6 TTC12 XKR6
Hypertension (Self-reported) 4.3 4 3 6.7 -0.66 3.4e-01 FAM86B3P FURIN TOP3A XKR6
Forced expiratory volume in 1-second (FEV1), predicted 2.1 2 0 0.0 0.00 1.0e+00 PTCH1 TOP3A
Whole body fat-free mass 1.7 5 2 4.4 -0.15 8.1e-01 FAM86B3P GATAD2A MMAB PTCH1 XKR6
Leg fat-free mass (right) 2.0 6 4 8.9 -0.07 9.0e-01 FAM86B3P FURIN GATAD2A MMAB PTCH1 XKR6
Arm fat percentage (left) 2.1 5 1 2.2 0.16 7.6e-01 ANKK1 EXD2 FAM86B3P TTC12 XKR6
Handedness (chirality/laterality): Left-handed 2.7 2 1 2.2 0.00 1.0e+00 FURIN PLEKHM1
Mood swings 10.8 8 6 13.3 0.99 6.8e-07 ANKK1 DRD2 FAM86B3P PLEKHM1 PTK2 RP11-165J3.6 TTC12 XKR6
Loneliness, isolation 5.2 2 0 0.0 0.00 1.0e+00 ORC4 PLEKHM1
Long-standing illness, disability or infirmity 3.4 2 0 0.0 0.00 1.0e+00 ANKK1 TTC12
Mouth/teeth dental problems: Mouth ulcers 2.5 1 1 2.2 0.00 1.0e+00 PLEKHM1
Medication for cholesterol 2.8 1 0 0.0 0.00 1.0e+00 PLEKHM1
Back pain experienced in last month 2.1 1 0 0.0 0.00 1.0e+00 PTK2
Medication: Aspirin 2.1 1 0 0.0 0.00 1.0e+00 FURIN
Smoking status: Current 3.3 2 0 0.0 0.00 1.0e+00 EXD2 XKR6
Forced expiratory volume in 1-second (FEV1), predicted percentage 2.6 1 1 2.2 0.00 1.0e+00 PLEKHM1
Whole body water mass 1.7 5 2 4.4 -0.16 8.0e-01 FAM86B3P GATAD2A MMAB PTCH1 XKR6
Leg predicted mass (right) 2.0 6 4 8.9 -0.07 9.0e-01 FAM86B3P FURIN GATAD2A MMAB PTCH1 XKR6
Arm fat mass (left) 2.3 4 2 4.4 -0.02 9.7e-01 ANKK1 FAM86B3P TTC12 XKR6
Number of self-reported non-cancer illnesses 3.0 2 0 0.0 0.00 1.0e+00 TOP3A TTC12
Average weekly champagne plus white wine intake 2.3 1 0 0.0 0.00 1.0e+00 C1orf123
Miserableness 10.5 9 6 13.3 0.98 2.3e-07 ANKK1 DRD2 FAM86B3P MMAB ORC4 PLEKHM1 RP11-165J3.6 TTC12 XKR6
Guilty feelings 9.4 7 4 8.9 0.98 2.0e-05 ANKK1 DRD2 FAM86B3P PLEKHM1 PTCH1 TTC12 XKR6
Medication: Blood pressure 4.2 4 3 6.7 -0.94 6.0e-02 FAM86B3P FURIN PLEKHM1 XKR6
High cholesterol (Self-reported) 2.1 1 1 2.2 0.00 1.0e+00 GATAD2A
Medication: Bendroflumethiazide 3.9 2 1 2.2 0.00 1.0e+00 FAM86B3P XKR6
Medication: Paracetamol 2.8 1 1 2.2 0.00 1.0e+00 PLEKHM1
Basal metabolic rate 1.7 5 2 4.4 -0.18 7.7e-01 FAM86B3P GATAD2A MMAB PTCH1 XKR6
Leg fat percentage (left) 2.6 5 1 2.2 0.31 5.4e-01 ANKK1 EXD2 FAM86B3P TTC12 XKR6
Arm fat-free mass (left) 1.6 3 1 2.2 0.00 1.0e+00 FAM86B3P PTCH1 XKR6
Number of operations (self-reported) 3.3 1 0 0.0 0.00 1.0e+00 FURIN
Average weekly beer plus cider intake 1.9 1 0 0.0 0.00 1.0e+00 XKR6
Irritability 9.5 7 3 6.7 0.96 5.3e-04 ANKK1 DRD2 FAM86B3P MMAB ORC4 PLEKHM1 XKR6
Fractured/broken bones in last 5 years 1.3 1 0 0.0 0.00 1.0e+00 PLEKHM1
Diastolic blood pressure, automated reading 2.8 3 3 6.7 0.00 1.0e+00 FAM86B3P FURIN XKR6
Ever depressed for a whole week 2.6 1 0 0.0 0.00 1.0e+00 PLEKHM1
Myopia 2.2 1 0 0.0 0.00 1.0e+00 GATAD2A
Vascular/heart problems diagnosed by doctor 4.3 4 2 4.4 0.64 3.6e-01 FAM86B3P FURIN TOP3A XKR6
Pain experienced in last month 3.1 3 0 0.0 0.00 1.0e+00 MMAB PLEKHM1 PTK2
Impedance of whole body 2.9 4 4 8.9 0.44 5.6e-01 FAM86B3P GATAD2A PLEKHM1 XKR6
Leg fat mass (left) 2.5 5 3 6.7 0.20 7.0e-01 ANKK1 EXD2 FAM86B3P TTC12 XKR6
Arm predicted mass (left) 1.6 3 2 4.4 0.00 1.0e+00 FAM86B3P PTCH1 XKR6

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 9 0.258 1.7
GTEx Adipose Visceral Omentum 11 0.540 1.8
GTEx Adrenal Gland 9 0.618 1.8
GTEx Artery Aorta 14 0.470 1.9
GTEx Artery Coronary 10 0.845 2.2
GTEx Artery Tibial 7 0.186 1.7
GTEx Brain Caudate basal ganglia 4 0.435 1.9
GTEx Brain Cerebellar Hemisphere 9 0.604 2.0
GTEx Brain Cerebellum 7 0.353 1.9
GTEx Brain Cortex 7 0.676 2.1
GTEx Brain Frontal Cortex BA9 6 0.649 2.1
GTEx Brain Hippocampus 4 0.763 2.1
GTEx Brain Hypothalamus 4 0.678 2.1
GTEx Brain Nucleus accumbens basal ganglia 7 0.809 2.1
GTEx Brain Putamen basal ganglia 5 0.801 2.1
GTEx Breast Mammary Tissue 11 0.557 1.8
GTEx Breast Mammary Tissue (Male) 7 0.587 2.0
GTEx Breast Mammary Tissue (Female) 13 0.791 1.9
GTEx Cells EBV-transformed lymphocytes 12 0.843 2.0
GTEx Cells Transformed fibroblasts 11 0.262 1.7
GTEx Colon Sigmoid 10 0.684 1.9
GTEx Colon Transverse 12 0.581 1.9
GTEx Esophagus Gastroesophageal Junction 9 0.623 2.0
GTEx Esophagus Mucosa 15 0.452 1.8
GTEx Esophagus Muscularis 14 0.433 1.9
GTEx Heart Atrial Appendage 9 0.570 1.9
GTEx Heart Left Ventricle 10 0.654 2.0
GTEx Liver 5 0.697 2.0
GTEx Lung 13 0.452 1.8
GTEx Muscle Skeletal 11 0.381 1.8
GTEx Nerve Tibial 10 0.231 1.7
GTEx Ovary 8 0.881 2.1
GTEx Pancreas 10 0.613 2.0
GTEx Pituitary 7 0.628 1.9
GTEx Prostate 6 0.719 1.9
GTEx Skin Not Sun Exposed Suprapubic 12 0.488 1.8
GTEx Skin Sun Exposed Lower leg 12 0.330 1.8
GTEx Small Intestine Terminal Ileum 6 1.302 2.3
GTEx Spleen 10 0.709 1.9
GTEx Stomach 7 0.481 2.0
GTEx Testis 11 0.349 1.8
GTEx Thyroid 14 0.350 1.8
GTEx Uterus 8 1.411 2.4
GTEx Vagina 6 0.945 2.1
GTEx Whole Blood 8 0.401 1.7
METSIM Adipose 1 0.022 1.5
NTR Blood 4 0.167 1.7
ROSMAP Brain Pre-frontal Cortex 8 0.182 1.6
YFS Blood 2 0.043 1.5
CommonMind Brain Pre-frontal Cortex 7 0.130 1.6
The Cancer Genome Atlas Bladder Urothelial Carcinoma 4 0.242 1.7
The Cancer Genome Atlas Breast Invasive Carcinoma 5 0.113 1.5
The Cancer Genome Atlas Cervical Squamous Cell Carcinoma 3 0.273 1.6
The Cancer Genome Atlas Colon Adenocarcinoma 2 0.097 1.5
The Cancer Genome Atlas Esophageal Carcinoma 3 0.438 1.7
The Cancer Genome Atlas Glioblastoma Multiforme 4 0.391 1.7
The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma 5 0.184 1.6
The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma 7 0.171 1.6
The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma 5 0.244 1.6
The Cancer Genome Atlas Brain Lower Grade Glioma 5 0.116 1.6
The Cancer Genome Atlas Liver Hepatocellular Carcinoma 4 0.362 1.6
The Cancer Genome Atlas Lung Adenocarcinoma 8 0.272 1.6
The Cancer Genome Atlas Lung Squamous Cell Carcinoma 6 0.239 1.6
The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma 4 0.251 1.6
The Cancer Genome Atlas Pancreatic Adenocarcinoma 4 0.241 1.6
The Cancer Genome Atlas Pheochromocytoma and Paraganglioma 4 0.301 1.5
The Cancer Genome Atlas Prostate Adenocarcinoma 9 0.195 1.6
The Cancer Genome Atlas Rectum Adenocarcinoma 2 0.289 1.5
The Cancer Genome Atlas Soft Tissue Sarcoma 3 0.281 1.7
The Cancer Genome Atlas Skin Cutaneous Melanoma 1 0.187 1.4
The Cancer Genome Atlas Stomach Adenocarcinoma 3 0.178 1.6
The Cancer Genome Atlas Testicular Germ Cell Tumors 5 0.391 1.6
The Cancer Genome Atlas Thyroid Carcinoma 9 0.174 1.6
The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma 2 0.394 1.6